Cargando…

Low free 25-hydroxyvitamin D and high vitamin D binding protein and parathyroid hormone in obese Caucasians. A complex association with bone?

BACKGROUND: Studies have shown altered vitamin D metabolism in obesity. We assessed differences between obese and normal-weight subjects in total, free, and bioavailable 25-hydroxyvitamin D (25(OH)D, 25(OH)D(Free), and 25(OH)D(Bio), respectively), vitamin D binding protein (DBP), parathyroid hormone...

Descripción completa

Detalles Bibliográficos
Autores principales: Saarnio, Elisa, Pekkinen, Minna, Itkonen, Suvi T., Kemi, Virpi, Karp, Heini, Ivaska, Kaisa K., Risteli, Juha, Koivula, Marja-Kaisa, Kärkkäinen, Merja, Mäkitie, Outi, Sievänen, Harri, Lamberg-Allardt, Christel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831036/
https://www.ncbi.nlm.nih.gov/pubmed/29489840
http://dx.doi.org/10.1371/journal.pone.0192596
Descripción
Sumario:BACKGROUND: Studies have shown altered vitamin D metabolism in obesity. We assessed differences between obese and normal-weight subjects in total, free, and bioavailable 25-hydroxyvitamin D (25(OH)D, 25(OH)D(Free), and 25(OH)D(Bio), respectively), vitamin D binding protein (DBP), parathyroid hormone (PTH) and bone traits. METHODS: 595 37-47-year-old healthy Finnish men and women stratified by BMI were examined in this cross-sectional study. Background characteristic and intakes of vitamin D and calcium were collected. The concentrations of 25(OH)D, PTH, DBP, albumin and bone turnover markers were determined from blood. 25(OH)D(Free) and 25(OH)D(Bio) were calculated. pQCT was performed at radius and tibia. RESULTS: Mean±SE (ANCOVA) 25(OH)D(Free) (10.8±0.6 vs 12.9±0.4 nmol/L; P = 0.008) and 25(OH)D(Bio) (4.1±0.3 vs 5.1±0.1 nmol/L; P = 0.003) were lower in obese than in normal-weight women. In men, 25(OH)D (48.0±2.4 vs 56.4±2.0 nmol/L, P = 0.003), 25(OH)D(Free) (10.3±0.7 vs 12.5±0.6 pmol/L; P = 0.044) and 25(OH)D(Bio) (4.2±0.3 vs 5.1±0.2 nmol/L; P = 0.032) were lower in obese. Similarly in all subjects, 25(OH)D, 25(OH)D(Free) and 25(OH)D(Bio) were lower in obese (P<0.001). DBP (399±12 vs 356±7mg/L, P = 0.008) and PTH (62.2±3.0 vs 53.3±1.9 ng/L; P = 0.045) were higher in obese than in normal-weight women. In all subjects, PTH and DBP were higher in obese (P = 0.047and P = 0.004, respectively). In obese women, 25(OH)D was negatively associated with distal radius trabecular density (R(2) = 0.089, P = 0.009) and tibial shaft cortical strength index (CSI) (R(2) = 0.146, P = 0.004). 25(OH)D(Free) was negatively associated with distal radius CSI (R(2) = 0.070, P = 0.049), radial shaft cortical density (CorD) (R(2) = 0.050, P = 0.045), and tibial shaft CSI (R(2) = 0.113, P = 0.012). 25(OH)D(Bio) was negatively associated with distal radius CSI (R(2) = 0.072, P = 0.045), radial shaft CorD (R(2) = 0.059, P = 0.032), and tibial shaft CSI (R(2) = 0.093, P = 0.024). CONCLUSIONS: The associations between BMI and 25(OH)D, 25(OH)D(Free), and 25(OH)D(Bio), DBP, and PTH suggest that obese subjects may differ from normal-weight subjects in vitamin D metabolism. BMI associated positively with trabecular bone traits and CSI in our study, and slightly negatively with cortical bone traits. Surprisingly, there was a negative association of free and bioavailable 25(OH)D and some of the bone traits in obese women.